NPI Details
SIPARADIGM LLC is a clinical medical laboratory in Pine Brook, NJ. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. SIPARADIGM LLC NPI is 1891909941. The provider is registered as an organization entity type.
The provider's business location address is:
25 RIVERSIDE DR STE 2
PINE BROOK, NJ
ZIP 07058-391
Phone: (201) 599-9044
Fax: (201) 599-9066
The provider's authorized official is Ruth Amicosante .
The authorized official title is Billing Manager and has the following contact phone number (650) 395-9124.
The CLIA number assigned to this NPI record is 31D1028659 - independent with a certificate type of Certificate of Accreditation.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
- Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
- Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
- Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
- Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
- Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
- Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
- Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
- Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
- Test for detecting genes associated with cancer (HCPCS:81455)
- Tissue culture for tumor disorders of bone marrow and blood cells (HCPCS:88237)
- Interpretation and report of genetic testing (HCPCS:88291)
- Chromosome analysis for genetic defects, analyze 20-25 cells (HCPCS:88264)
- Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
- Bone marrow, smear interpretation (HCPCS:85097)
- Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
- Microscopic genetic analysis of tissue, manual, initial procedure (HCPCS:88368)
- Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
- Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
- Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
- Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
- Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source (HCPCS:G2024)
- Flow cytometry technique for dna or cell analysis, 9 to 15 markers (HCPCS:88188)
- Translocation analysis (bcr/abl1) major breakpoint (HCPCS:81206)
- Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
- Microscopic genetic analysis of tumor, manual (HCPCS:88360)
- Gene rearrangement analysis (immunoglobulin heavy chain locus), variable region somatic mutation analysis (HCPCS:81263)
- Interpretation and report of genetic testing (HCPCS:88291)
- Test for detecting genes associated with blood related cancer (HCPCS:81450)
- Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
- Microscopic genetic analysis of tissue, manual, initial procedure (HCPCS:88368)
- Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
- Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
- Gene analysis (janus kinase 2) variant (HCPCS:81270)
- Test for detecting genes associated with cancer of body organ (HCPCS:81445)
- Bone marrow, smear interpretation (HCPCS:85097)
- Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
- Microscopic genetic analysis of tumor, manual (HCPCS:88360)
- Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Gene analysis (v-raf murine sarcoma viral oncogene homolog b1) (HCPCS:81210)
- Microscopic genetic analysis of tissue, manual, each additional procedure (HCPCS:88369)
- Flow cytometry technique for dna or cell analysis, 9 to 15 markers (HCPCS:88188)
- Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
- Gene analysis (calreticulin), common variants (HCPCS:81219)
- Translocation analysis (bcr/abl1) minor breakpoint (HCPCS:81207)
- Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants (HCPCS:81162)
- Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS:81307)
- Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
- Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS:81317)
- Microsatellite instability analysis (HCPCS:81301)
- Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis (HCPCS:81295)
- Gene analysis (muts homolog 6 [e coli]) full sequence analysis (HCPCS:81298)
- Surgical pathology consultation and report on referred material requiring preparation of slides (HCPCS:88323)
- Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
- Gene analysis (myeloid differentiation primary response 88) for p.leu265pro variant (HCPCS:81305)
- Chromosome analysis for genetic defects, count 15-20 cells (HCPCS:88262)
- Gene analysis (abl proto-oncogene 1, non-receptor tyrosine kinase) (HCPCS:81170)
- Gene analysis (epidermal growth factor receptor), common variants (HCPCS:81235)
- Chromosome analysis for genetic defects, additional karyotypes, each study (HCPCS:88280)
- Pathologist examination, dissection, and preparation of tissue (HCPCS:88387)
- Flow cytometry technique for dna or cell analysis, 2 to 8 markers (HCPCS:88187)
- Gene analysis (adenomatous polyposis coli), full gene sequence (HCPCS:81201)
- Genetic sequencing localization, initial procedure (HCPCS:88365)
- Gene analysis (v-ki-ras2 kirsten rat sarcoma viral oncogene) variants in codons 12 and 13 (HCPCS:81275)
The enumeration date for this NPI number is 5/9/2007 and was last updated on 3/30/2023.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 291U00000X | Clinical Medical Laboratory | | 25MA05880800 | NEW JERSEY | No |
| 2 | 291U00000X | Clinical Medical Laboratory | | | | No |
| 3 | 291U00000X | Clinical Medical Laboratory | | 00007503 | NEW JERSEY | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | P00213695 | OTHER | | RAILROAD |
| 2 | SI0S64U020 | OTHER | | EMPIRE BCBS |
| 3 | 000000039833 | OTHER | | BOSTON MEDICAL CENTER |
| 4 | 269580 | OTHER | | AMERIGROUP |
| 5 | 250588080 | OTHER | | HIPUSA |
| 6 | 7262661 | OTHER | | AETNA |
| 7 | 0066222 | MEDICAID | NEW JERSEY | |
| 8 | 427253 | OTHER | | TUFTS HEALTH PLAN |
| 9 | 60013223 | OTHER | | HORIZON NJ HEALTH |
| 10 | 9759537 | OTHER | | GHI |
| 11 | A3638184 | OTHER | | OXFORD HEALTH PLAN |
| 12 | J35526 | OTHER | | HEALTHNET |
